The International Bone and Mineral Society gratefully acknowledges the support of its partners:
The Alliance for Better Bone Health | Amgen | Chugai Pharmaceutical
Lilly | Merck | Novartis | Nycomed | Teijin
Information about Procter & Gamble Pharmaceuticals is available at www.pgpharma.com.
Information about Sanofi aventis is available at www.sanofi-aventis.com.
Information about Amgen Inc. is available at www.amgen.com.
Chugai Pharmaceutical aspires for development of innovative drugs by integrating cutting-edge technologies into its unique drug discovery infrastructure. Funneling resources into prescription drugs, Chugai is pursuing research and development of antibody drug-centered biopharmaceuticals in five franchises; cancer, renal, cardiovascular, bone/joint, and transplantation/immunology/infectious diseases while actively working on the traditional chemical cynthesis drug discovery. Based on high ethical and moral standards for a life science enterprise, Chugai, with its Patient-First philosophy, is committed to contributing to society by developing innovative drugs enabling higher patients' QOL and better lives.
Additional information about Chugai is available at www.chugai-pharm.co.jp.
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.
Additional information about Lilly is available at www.lilly.com.
Merck, Sharp, and Dohme, Inc. (MSD) is a global, research-driven pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human health products. MSD, the manufacturer of FOSAMAX® (alendronate sodium), is a leader in osteoporosis research and treatment.
Additional information about MSD is available at www.merck.com.
Information about Novartis is available at www.novartis.com.
Nycomed is a European pharmaceutical company. Rapidly expanding, Nycomed now operates in 19 European countries including Russia / CIS. We provide hospital/specialist products throughout Europe and GP & OTC products in selected markets. Within the field of osteoporosis, Nycomed is currently partnering with NPS pharmaceuticals on the development of full-length PTH (1-84) which stimulates growth of structurally-normal bone lost to the disease. This product is expected to further strengthen Nycomed’s existing osteoporosis position built through its Nycomed Calcium & Vitamin D3 portfolio.
If you want to learn more about us please visit our website: www.nycomed.com.
Information about Teijin is available at www.teijin-pharma.co.jp
2010 BoneKEy Sponsors
Information about Amgen Inc. is available at www.amgen.com.
Information about Procter & Gamble Pharmaceuticals is available at www.pgpharma.com.
Information about Sanofi aventis is available at www.sanofi-aventis.com.
Information about Lilly is available at www.lilly.com.
Collective Membership Society Sponsors